1,624
Views
6
CrossRef citations to date
0
Altmetric
Psoriasis

Treating moderate plaque psoriasis: prospective 6-month chart review of patients treated with apremilast

, &
Pages 430-434 | Received 01 Jun 2018, Accepted 31 Jul 2018, Published online: 26 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pooja Kulkarni & Ashwini Deshpande. (2021) Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review. Critical Reviews in Analytical Chemistry 51:3, pages 258-267.
Read now

Articles from other publishers (5)

Kristian Reich, Bernhard Korge, Nina Magnolo, Maria Manasterski, Uwe Schwichtenberg, Petra Staubach-Renz, Stephan Kaiser, Josefine Roemmler-Zehrer, Natalie Núnez Gómez & Katrin Lorenz-Baath. (2021) Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO. Dermatology and Therapy 12:1, pages 203-221.
Crossref
Alice B. Gottlieb, Joseph F. Merola, Joshua Cirulli, Catherine C. Williams, Gregory J. Linowski, Maria Paris, Heather J. Litman, Ning Guo, Kelechi Emeanuru, Robert R. McLean, Angel Cronin & Bruce Strober. (2021) Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry. Dermatology and Therapy 11:1, pages 253-263.
Crossref
A.‐C. Fougerousse, F. Maccari, A. Beauchet, J. Parier, C. Boulard, P.‐A. Becherel, N. Quiles‐Tsimaratos, T. Le Guyadec, D. Thomas‐Beaulieu, B. Halioua, E. Begon, M. Bastien, J.‐L. Perrot, V. Pallure, P. Bilan, M. Steff, P. Pfister, A. Vermersch‐Langlin, T. Boyé, L. Mery‐Bossard, H. Maillard, M. Kemula, C. Girard, C. Poiraud, J.‐B. Monfort, I. Kupfer‐Bessaguet, M. Perrussel, D. Lons‐Danic, N. Sultan, E. Lorier, M. Zeitoun, L. Wagner, G. Gabison & E. Mahé. (2019) Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting. Journal of the European Academy of Dermatology and Venereology 33:12.
Crossref
O. Yu. Olisova, D. A. Svistunova, L. M. Chernyavskaya & E. M. Anpilogova. (2019) Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis. Vestnik dermatologii i venerologii 95:2, pages 74-80.
Crossref
. (2019) Apremilast. Reactions Weekly 1762:1, pages 59-59.
Crossref